| Literature DB >> 35377638 |
Tianyu He1, Tiffany C Edwards1, Jiashu Xie1, Hideki Aihara2, Robert J Geraghty1, Zhengqiang Wang1.
Abstract
Human cytomegalovirus (HCMV) terminase complex entails a metal-dependent endonuclease at the C-terminus of pUL89 (pUL89-C). We report herein the design, synthesis, and characterization of dihydroxypyrimidine (DHP) acid (14), methyl ester (13), and amide (15) subtypes as inhibitors of HCMV pUL89-C. All analogs synthesized were tested in an endonuclease assay and a thermal shift assay (TSA) and subjected to molecular docking to predict binding affinity. Although analogs inhibiting pUL89-C in the sub-μM range were identified from all three subtypes, acids (14) showed better overall potency, substantially larger thermal shift, and considerably better docking scores than esters (13) and amides (15). In the cell-based antiviral assay, six analogs inhibited HCMV with moderate activities (EC50 = 14.4-22.8 μM). The acid subtype (14) showed good in vitro ADME properties, except for poor permeability. Overall, our data support the DHP acid subtype (14) as a valuable scaffold for developing antivirals targeting HCMV pUL89-C.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35377638 PMCID: PMC9441020 DOI: 10.1021/acs.jmedchem.2c00203
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 8.039